A biological evaluation must be done to assess the biocompatibility related risks associated with the use of the medical device with direct and/or indirect contact with human tissue or body.
This assessments should help determine the potential for an unacceptable adverse biological response, unless you can justify that the materials have a long history of safe use in medical devices that come in contact with human skin, body or tissue. Since this is an inhaler you probably need sufficient rationale to justify not performing biocompatibility tests. So the question is- Is the inhaler considered an intact skin contacting medical device?
---------------------------------
Noreen Svensson
1187 EE Amstelveen
Netherlands
---------------------------------
Original Message:
Sent: 16-Aug-2023
From: Anoosha Bhat
Subject: Clarity on ISO 10993 for medical devices
Hi all,
Please guide me on below.
We are manufacturing Metered Dose Inhaler medical device. Do we have to prove the biocompatibility of all the parts of the device or testing the biocompatibility of the parts that comes in contact with the human body alone would suffice for product registration?
Also, do we have to test the biocompatibility of the parts of the device that comes in the breathing air pathway of MDI?
------------------------------
Anoosha Bhat
Bengaluru
India
------------------------------